Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome
Synonyms: SJS/TEN overlap syndrome | Stevens-Johnson/TEN overlap syndrome | Stevens-Johnson/toxic epidermal necrolysis overlap syndrome
An intermediate form of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum characterized by destruction and detachment of the skin epithelium involving between 10 to 29% of the body surface area and mucous membranes. Onset usually occurs 4-28 days after administration of the causal medication and is most frequently associated with anticonvulsants antibacterial sulfonamides allopurinol nevirapine and oxicams (non-steroidal anti-inflammatory drugs) but many other medications have also been implicated. The disease is not induced by medication in 15% of cases. Histology is characterized by an epidermal necrolysis. Multiple disabling long-term sequelae (especially cutaneous ocular and psychological) are frequent.
Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.
Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http: //www.orphadata.org. Data version September 2023.
Newly diagnosed with
Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome?
Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.